Double digital sales and profit growth have been reported at the German parent of Huddersfield pharmaceuticals manufacturer Thornton & Ross.
Stada saw group sales increase 16% to €2.1bn while Ebitda jumped 30% to €509m in half year results it said were its best ever. CEO of the healthcare group Peter Goldschmidt said it was on target to exceed €4bn sales and €1bn Ebitda.
Growth was driven by new drug launches and extended product lines, including a 19% sales boost across the group's consumer healthcare division - the largest of Stada's three business segments. The group secured distribution agreements for Sanofi's entire consumer healthcare portfolio in about 30 European and Eurasian countries, and recently acquired several brands from the French multinational, including Antistax, Lomudal and Omnivit.
Read more: Power lines cooling tech firm nets £2.25m investment from Northern Gritstone
Meanwhile across Stada's generics business, adjusted sales grew 8% to €756.2m thanks to new market share gained across countries such as Austria, Denmark and Lithuania. And the group's speciality division sales were ahead 24% on an adjusted basis to €432.1m.
Nigel Stephenson, Stada 海角视频 general manager, said: "In line with the overall group performance, we are growing strongly ahead of the 海角视频 market in consumer healthcare, not least through appealing extensions to brands such as Cetraben, Savlon and Zoflora. For example, the launch of Cetraben Pro Hydrate Five enables us to reach a potential target market of 11 million 海角视频 shoppers, with good growth potential and an ambitious multi-media marketing campaign launched this summer.
"Zoflora continues to bring new fragrances and products such as carpet care foam to market, and we’re proud to have seen the team recently win at the Grocer Gold Awards, taking the 2023 Household Goods Brand of the Year accolade. We continue to be a trusted partner to the National Health Service (NHS), not least through offering competition on high-cost molecules such as apixaban and winning an NHS tender for the biological ophthalmology drug ranibizumab."
Thornton & Ross is the maker of cough syrup brand Covonia, headlice remedy Hedrin and household cleaning products under the Zoflora brand.